New Urine Drug Test for Spice and K2

20 /PRNewswire/ -- Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids, also referred to as "herbal incense" products. Dominion's new in-house assay can detect the primary metabolites of the synthetic cannabinoids, JWH-018 and JWH-073, in urine by Ultra Performance Liquid Chromatography/Tandem Mass Spectrometry (UPLC/MS/MS). These may be contributing factors to some of the adverse effects reported by users including panic attacks, paranoia, heart palpitations, respiratory issues, impaired motor skills, agitation, and altered mood and perception.* "At Dominion, we recognize the issues that the field has encountered with these newer synthetic and unregulated products," stated Chief Operating Officer Stephen Jordan. Dominion Diagnostics is a premier provider of comprehensive clinical quantitative urine pass drug test, medication monitoring, and support services nationwide. For over 13 years, Dominion has provided services to thousands of clients in a variety of medical specialties, including Pain Medicine, Primary Care, Addiction Treatment, Behavioral Health, Psychiatry and Hospital Systems.